Patients with invasive bladder cancer or those equivalent cancer who are undergoing radical cystectomy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed as bladder cancer by histological examination Clinical stage of T2-3N0M0 or BCG resistant TisN0M0 Informed consent is obtained from the patient
Exclusion criteria
Exclusion criteria: Active other malignancy History of lower abdominal surgery Severe heart disease Severe hepatic disease Anti-coagulant therapy cannot stop Sever obesity such as BMI > 35 Patients without informed consent Any other reasons inappropriate for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of surgery, blood loss, perioperative and postoperative complications, histology of surgical specimen | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrent free survival, overall survival | — |
Countries
Japan
Contacts
Ibaraki Prefectural Central Hospital Department of Urology